Atlas Trials

Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol.

Clinical trial NCT03226067 · COMPLETED

Trial details

NCT number
NCT03226067
Sponsor
Calliditas Therapeutics AB
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Biliary Cirrhosis
Start date
2017-06-26
Primary completion
2019-04-11
Enrollment
111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.